October 30, 2024
Carisma Therapeutics Announces Changes to its Board of Directors
Media
October 30, 2024
Pulmonx Reports Third Quarter 2024 Financial Results
October 30, 2024
SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
October 29, 2024
Aro Biotherapeutics Opens Enrollment of Phase 1b Trial of ABX1100 in Patients with Late-Onset Pompe Disease (LOPD)
October 28, 2024
Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates
October 24, 2024
BONESUPPORT HOLDING AB (publ) – publishes Q3 2024 Interim report
October 22, 2024
Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024
October 22, 2024
Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024
October 18, 2024
Correction: BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2024
October 17, 2024
BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2024